There is a sell-off in the stock market on Tuesday and many major support levels have been broken. Panic selling is happening in the market and many large-cap stocks are under pressure. In this sell-off in the market, some penny stocks are trading in the upper circuit with heavy volume.

Pharma sector penny stock Remedium Lifecare Ltd hit an upper circuit on Tuesday with a gain of 5%. During this period, 13.63 lakh shares were traded on BSE. That is, the stock saw heavy volume.

Remedium Lifecare's share price is rising above its 52-week low of Rs 5.27. It is a multibagger stock, whose 52-week high is Rs 38.25. Although its return has been negative in the last one year, but in the last five years, this stock has given a growth of 2700%.

Remedium Lifecare is a Hyderabad-based pharmaceutical company and has split its shares. It has also issued bonus equity for two consecutive years in the years 2023 and 2024. After the corporate action, the stock price was adjusted below Rs 10.

During Tuesday's trading session, the stock opened at Rs 5.57, up two per cent from its previous close of Rs 5.46. The stock touched the upper price band of 5 per cent to Rs 5.73.

This pharma sector penny stock has been trading higher for the last two consecutive sessions. It is above the 5-day moving average but below the 20-day, 50-day, 100-day and 200-day moving averages.

Remedium Lifecare is a microcap company which is in the business of advanced pharmaceutical intermediates, APIs and other pharma products.
 

Remedium Lifecare Stock Split, Bonus

Remedium Lifecare had issued bonus shares in the ratio of 3:1 (three for one) in July this year, immediately after the stock split which became effective in the ratio of 5:1 (five for one).

In the year 2023, the pharma company first issued bonus shares in the ratio of 9:5 (nine shares for every five) and then split the face value of equity shares in the ratio of 2:1 (two for one).
Remedium Lifecare Share Price History

Remedium Lifecare is one of the best performing stocks. This stock has given great returns to its investors in the long term. According to exchange data, the pharma stock has recorded a decline of 78 percent in investors' money in the last one year. However, this stock has registered a jump of 351 percent in the last two years and 370 percent in three years. In the last 5 years, the pharma stock has seen a tremendous rise of 2765 percent.